CD9 and infection: Similarly, it was previously shown that the treatment of cells with antibodies specific for the Tspans CD9, CD63, and CD81 reduced the infection by the coronavirus MHV and SARS-CoV, MERS-CoV, and HCoV-229E pseudovirus transductions in susceptible cells [25].